Zolgensma

• Business
• Education
• Financial
• Healthcare
• Industrial
• Investment
• Management
• News
• Pharma & Biotech
• Science
• Security & Safety
• Switzerland
• Technology

Novartis Unveils Promising Results from SMART Study: Zolgensma’s Efficacy Confirmed in Older and Heavier SMA Patients

(IN BRIEF) Novartis has presented compelling data from the SMART study, reinforcing the clinical advantages of Zolgensma® (onasemnogene abeparvovec) in…